Cargando…
Glycine Transport Inhibitors for the Treatment of Schizophrenia
Multiple lines of evidence indicate that hypofunction of glutamatergic neurotransmission via N-methyl-D-aspartate (NMDA) receptors might be implicated in the pathophysiology of schizophrenia, suggesting that increasing NMDA receptor function via pharmacological manipulation could provide a new strat...
Autor principal: | Hashimoto, Kenji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023951/ https://www.ncbi.nlm.nih.gov/pubmed/21253021 http://dx.doi.org/10.2174/1874104501004010010 |
Ejemplares similares
-
A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2
por: Erdem, Fatma Asli, et al.
Publicado: (2019) -
In Vivo Evaluation of (11)C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain
por: Zhang, Ji-chun, et al.
Publicado: (2012) -
Pharmacological Characterization of [(3)H]CHIBA-3007 Binding to Glycine Transporter 1 in the Rat Brain
por: Zhang, Jichun, et al.
Publicado: (2011) -
A Role for Accumbal Glycine Receptors in Modulation of Dopamine Release by the Glycine Transporter-1 Inhibitor Org25935
por: Lidö, Helga Höifödt, et al.
Publicado: (2011) -
Analysis of Binding Determinants for Different Classes of Competitive and Noncompetitive Inhibitors of Glycine Transporters
por: Łątka, Kamil, et al.
Publicado: (2022)